1. Acknowledgement to Referees

   ACKNOWLEDGEMENT TO REFEREES 30 October 2023 Pages: 615 - 617

2. Use of Clearance Concepts to Simulate Impact of Interleukin-6 on Drug Elimination Governed by Cytochromes P450 3A4 and Glomerular Filtration Rate

   • Xiang Chen
   • Guo Yu
   • Guo-Fu Li

   Commentary 04 October 2023 Pages: 619 - 621

3. Unraveling the Effects of Acute Inflammation on Pharmacokinetics: A Model-Based Analysis Focusing on Renal Glomerular Filtration Rate and Cytochrome P450 3A4-Mediated Metabolism

   • Feiyan Liu
   • Linda B. S. Aulin
   • J. G. Coen van Hasselt

   Original Research Article Open access 15 September 2023 Pages: 623 - 631

   

4. Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations

   • Laure Chauchat
   • Camille Guerin
   • Jean-Paul Renard

   Original Research Article Open access 08 September 2023 Pages: 633 - 645

   

5. Population Pharmacokinetic Analysis of Vancomycin in Patients with Solid or Hematological Malignancy in Relation to the Quick Sequential Organ Failure Assessment Scores

   • Yasumasa Tsuda
   • Masahiro Takahashi
   • Hirotoshi Echizen

   Original Research Article 11 September 2023 Pages: 647 - 655

   

6. Effect of Moderate Malnutrition on the Pharmacokinetics of Etoposide and Vincristine in Freshly Weaned Rats

   • Megha Garg
   • Khushboo Gandhi
   • Vikram Gota

   Original Research Article 12 September 2023 Pages: 657 - 663

   

7. Pharmacokinetics and Safety of Long-Acting Release Formulations of Pasireotide (SOM230) in a Male Population Who Are Hyperendemic Hepatitis B/C and Chronic Kidney Disease: An Open-Label, Phase I Study

   • Chun-Jui Huang
   • Chieh-Hua Lu
   • Kuang-Chung Shih

   Original Research Article 26 September 2023 Pages: 665 - 674

   

8. Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin^®) in Patients with Non-squamous Non-small Cell Lung Cancer

   • Joel S. Owen
   • Russell J. Rackley
   • Mark A. Socinski

   Original Research Article 04 October 2023 Pages: 675 - 689

   

9. The Pharmacokinetic Profile of Palovarotene: An Open-Label Phase I Trial Investigating the Effect of Food and Potential for Drug–Drug Interaction in Healthy Participants

   • Rose Marino
   • Louise Dube
   • Kim-Hanh Le Quan Sang

   Original Research Article Open access 07 October 2023 Pages: 691 - 707

   

10. The Effects of 16-HETE Enantiomers on Hypertrophic Markers in Human Fetal Ventricular Cardiomyocytes, RL-14 Cells

    • Rahmat Hidayat
    • Mahmoud A. El-Ghiaty
    • Ayman O. S. El-Kadi

    Original Research Article 10 October 2023 Pages: 709 - 722

    

11. Pharmacokinetics, Mass Balance and Metabolism of [¹⁴C]HSK21542, a Novel Kappa Opioid Receptor Agonist, in Humans

    • Jin-jie Yuan
    • Yi-cong Bian
    • Li-yan Miao

    Original Research Article 13 October 2023 Pages: 723 - 731

    

12. Effect of Verapamil, a P-glycoprotein-1 and Cytochrome P450 3A4 Inhibitor, on Pharmacokinetics and Metabolic Stability of Ripretinib: A Drug–Drug Interaction Study in Rats

    • Shyamala Mudavath
    • Dongamanti Ashok

    Original Research Article 13 October 2023 Pages: 733 - 746